Patheon acquire IRIX Pharmaceuticals

Patheon to acquire IRIX Pharmaceuticals

12:01 PM, 5th March 2015
Patheon to acquire IRIX Pharmaceuticals

DURHAM, US: Patheon, a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, announced it has reached a definitive agreement to acquire IRIX Pharmaceuticals, a company headquartered in Florence, South Carolina, US that specializes in difficult to manufacture Active Pharmaceutical Ingredient (API) needs for drugs from early and late development, through commercial launch. Patheon will purchase IRIX and expects to close the transaction in the next 60 days.

Patheon secures additional API development and manufacturing services in the US, including high-potency (SafeBridge Class IV certified) and controlled substances (Schedule 1-4), better meeting customers’ most challenging needs. IRIX has a well-established reputation for the optimization of chemical processes and scale up for commercial API manufacturing at sites in Greenville and Florence.

Patheon and IRIX combined, offer an array of cutting edge process technologies, including biocatalysis, homogeneous catalysis and microreactors, and are well positioned to address an extensive range of supply chain issues for customers.

“Combining companies with shared commitments to both scientific excellence and customer service drives industry excellence, and we are excited to become part of the Patheon network. This is a strategic deal that allows us to help customers solve complex challenges with comprehensive, integrated solutions,” said Guy Steenrod, Chief Executive Officer, IRIX.


© Worldofchemicals News 



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

Huntsman to cut 120 jobs in pigments, additives sector

THE WOODLANDS, US: Huntsman Corporation announced plans to restructure its Color Pigments business, another step in its previously announced plan to s ...

Read more
Researchers create lab-on-paper for rapid, inexpensive medical diagnostics

KINGSTON, US: A team of University of Rhode Island engineers led by Professor Mohammad Faghri has created a new paper-based platform for conducting a ...

Read more
Arkema acquires organic peroxides company, Oxido

COLOMBES, FRANCE: Arkema reinforces its organic peroxide operations with the acquisition of Italian company Oxido, a European player in the formulatio ...

Read more
Energy-generating cloth could replace batteries in wearable devices

WASHINGTON DC, US: From light-up shoes to smart watches, wearable electronics are gaining traction among consumers, but these gadgets’ versatili ...

Read more
Building metal-organic framework with bioactive curcumin

BEIJING, CHINA: Curcumin is top of the ingredients list for a highly porous metal–organic framework (MOF) being developed by scientists in China ...

Read more
BASF to expand specialty amines capacity in Ludwigshafen, Germany

LUDWIGSHAFEN, GERMANY: BASF is significantly expanding its production capacity for about 20 specialty amines at its Verbund site in Ludwigshafen, Germ ...

Read more